藥明生(sheng)(sheng)(sheng)物在成(cheng)功實現(xian)WuXiUP?中(zhong)試(shi)規模(mo)(mo)全(quan)(quan)連(lian)續(xu)(xu)生(sheng)(sheng)(sheng)產(chan)的(de)基礎上，通過引入膜層(ceng)析、自動化(hua)(hua)(hua)控制等前沿技(ji)術(shu)(shu)，并對PAT技(ji)術(shu)(shu)進行迭代優化(hua)(hua)(hua)，進一步實現(xian)中(zhong)試(shi)規模(mo)(mo)的(de)全(quan)(quan)自動化(hua)(hua)(hua)原液(ye)連(lian)續(xu)(xu)生(sheng)(sheng)(sheng)產(chan)。經升級(ji)的(de)WuXiUP?全(quan)(quan)自動化(hua)(hua)(hua)連(lian)續(xu)(xu)生(sheng)(sheng)(sheng)產(chan)平(ping)臺將(jiang)在提升生(sheng)(sheng)(sheng)產(chan)效率和產(chan)品質量方面(mian)發揮更大作(zuo)用(yong)，賦能客戶加速生(sheng)(sheng)(sheng)物藥從研發到商業(ye)化(hua)(hua)(hua)的(de)全(quan)(quan)流(liu)程。（美通社）